Agios Pharmaceuticals (AGIO) FCF Margin Growth (1y) (2013 - 2026)
Agios Pharmaceuticals (AGIO) FCF Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Agios Pharmaceuticals |
2.01 Bn |
2.01 Bn |
19.43 Mn |
70,376.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
70,376.00 |
| Dec 31, 2025 |
76,261.00 |
| Sep 30, 2025 |
24,771.00 |
| Jun 30, 2025 |
21,544.00 |
| Mar 31, 2025 |
-6,067.00 |
| Dec 31, 2024 |
-23,955.00 |
| Sep 30, 2024 |
-10,080.00 |
| Jun 30, 2024 |
14,254.00 |
| Mar 31, 2024 |
48,456.00 |
| Dec 31, 2023 |
52,720.00 |
| Sep 30, 2023 |
132,123.00 |
| Jun 30, 2023 |
31,387.00 |
| Mar 31, 2023 |
1.02 Mn |
| Dec 31, 2020 |
17,020.00 |
| Sep 30, 2020 |
17,434.00 |
| Jun 30, 2020 |
6,666.00 |
| Mar 31, 2020 |
25,313.00 |
| Dec 31, 2019 |
-5,189.00 |
| Sep 30, 2019 |
9,333.00 |
| Mar 31, 2019 |
78,839.00 |
